Gain Therapeutics Inc. (GANX)
Market Closed
17 Jul, 20:00
NASDAQ (NMS) NASDAQ (NMS) Primary $
1. 71
+0.05
+3.012%
$
71.66M Market Cap
- P/E Ratio
- Div Yield
501,200 Volume
-1.19 Eps
$ 1.66
Previous Close Investors:
Want to track GANX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Gain Therapeutics Inc. Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
 David Einhorn Greenlight Capital Re Ltd. | 588,410 | $8.29M | $988,528.8 | -$7.3M | -88.08% |
| MFA Millington Financial Advisors LLC Millington Financial Advisors LLC | 15,000 | $29,250 | $24,825 | -$4,425 | -15.13% |
